BMRN
BioMarin Pharmaceutical Inc. · Healthcare
CEO Jean Jacques Bienaime sold $704K of BioMarin Pharmaceutical Inc.
Sold$703,600
$87.95Price
8,000Shares
−2%Stake
What BMRN did after the filing
Prices for BMRN after this filing aren't in yet.
Traded Tue, Jan 14. Filed Thu, Jan 16, 8:00 PM ET, after the close. Not investment advice.